Clinical experience with stem cells and other cell therapies in neurological diseases

被引：31

作者：

Karussis, Dimitrios

Petrou, Panayiota

Kassis, Ibrahim

机构：

[1] Hadassah Univ Hosp, Dept Neurol, MS Ctr, IL-91120 Jerusalem, Israel

[2] Hadassah Univ Hosp, Lab Neuroimmunol, Agnes Ginges Ctr Neurogenet, IL-91120 Jerusalem, Israel

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2013年 / 324卷 / 1-2期

关键词：

Stem cells; Mesenchymal stem cells; Neurological diseases; Clinical trials; PROGRESSIVE MULTIPLE-SCLEROSIS; AMYOTROPHIC-LATERAL-SCLEROSIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FETAL NEURAL TRANSPLANTS; MARROW STROMAL CELLS; HUNTINGTONS-DISEASE; ANIMAL-MODEL; CONDITIONING REGIMEN; DOPAMINE NEURONS; STRIATAL GRAFTS;

D O I：

10.1016/j.jns.2012.09.031

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

To overcome the limited capacity of the CNS for regeneration, the theoretical alternative would be to use stem cells for more effective management of chronic degenerative and inflammatory neurological conditions, and also of acute neuronal damage from injuries or cerebrovascular diseases. Although the adult brain contains small numbers of stem cells in restricted areas, this intrinsic stem cell repertoire is small and does not measurably contribute to functional recovery. Embryonic cells carrying pluripotent and self-renewal properties represent the stem cell prototype, but there are additional somatic stem cells that may be harvested and expanded from various tissues during adult life. Stem cell transplantation is based on the assumption that such cells may have the potential to regenerate or support the survival of the existing, partially damaged cells. This review summarizes the state-of-the-art and the clinical worldwide experience with the use of various types of stem cells in neurological diseases. (C) 2012 Elsevier B.V. All rights reserved.

引用

页码：1 / 9

页数：9